BridgeBio Oncology Therapeutics, Inc. BBOT
- BBO-11818 — Non-Small Cell Lung Cancer Phase 1
- BBO-11818 — Colorectal Cancer Phase 1
- BBO-11818 — Pancreatic Ductal Adenocarcinoma Phase 1
KRAS G12D (4 companies · 10 programs)
Companies with an active program directed at KRAS G12D.
Revolution Medicines, Inc. RVMD
- zoldonrasib — Pancreatic Ductal Adenocarcinoma Phase 3
- zoldonrasib — Non-Small Cell Lung Cancer Phase 3
- zoldonrasib — Colorectal Cancer Phase 3
Verastem, Inc. VSTM
- VS-7375 — Pancreatic Ductal Adenocarcinoma Phase 2
- VS-7375 — Non-Small Cell Lung Cancer Phase 2
- VS-7375 — Colorectal Cancer Phase 2
ARVINAS, INC. ARVN
- ARV-806 — Solid Tumors Phase 1